| pubmed-article:9037280 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9037280 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:9037280 | lifeskim:mentions | umls-concept:C0039601 | lld:lifeskim |
| pubmed-article:9037280 | lifeskim:mentions | umls-concept:C0694643 | lld:lifeskim |
| pubmed-article:9037280 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:9037280 | lifeskim:mentions | umls-concept:C0426731 | lld:lifeskim |
| pubmed-article:9037280 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9037280 | pubmed:dateCreated | 1997-3-14 | lld:pubmed |
| pubmed-article:9037280 | pubmed:abstractText | This study examined the effects of testosterone replacement using a nonscrotal testosterone transdermal (TTD) system on prostate size and prostate-specific antigen (PSA) levels in hypogonadal men. | lld:pubmed |
| pubmed-article:9037280 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9037280 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9037280 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9037280 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9037280 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9037280 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9037280 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9037280 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9037280 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9037280 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:9037280 | pubmed:issn | 0090-4295 | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:MeikleA WAW | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:AdolfssonJJ | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:MiddletonR... | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:SandersS WSW | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:MazerN ANA | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:StephensonR... | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:HooverD RDR | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:ArverSS | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:DobsA SAS | lld:pubmed |
| pubmed-article:9037280 | pubmed:author | pubmed-author:RajaramLL | lld:pubmed |
| pubmed-article:9037280 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9037280 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:9037280 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9037280 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9037280 | pubmed:pagination | 191-6 | lld:pubmed |
| pubmed-article:9037280 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:meshHeading | pubmed-meshheading:9037280-... | lld:pubmed |
| pubmed-article:9037280 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9037280 | pubmed:articleTitle | Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. | lld:pubmed |
| pubmed-article:9037280 | pubmed:affiliation | Department of Medicine, University of Utah, Salt Lake City 84132, USA. | lld:pubmed |
| pubmed-article:9037280 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9037280 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9037280 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9037280 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9037280 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9037280 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9037280 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9037280 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9037280 | lld:pubmed |
